AmreenHusainMD

Obstetrics & Gynecology • Stanford, CA

Gynecologic Oncology

Genentech BioOncology Inc

Join to view full profile

Dr. Husain is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Husain's full profile

Already have an account?

Office
875 Blake Wilbur Dr
# Stanford
Stanford, CA 94304
Phone+1 408-885-5000

Fax+1 651-498-5618

Education & Training

New York Presbyterian Hospital (Cornell Campus)Residency, Obstetrics and Gynecology, 1991 - 1995
New York Medical CollegeClass of 1991
Memorial Sloan Kettering Cancer CenterFellowship, Gynecologic Oncology

Certifications & Licensure

CA State Medical License 2000 - 2026

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2012-2014
America's Top Doctors for Cancer Castle Connolly, 2011-2013

Publications & Presentations

PubMed

178 citations
Atezolizumab and nab-Paclitaxel in Advanced Triple-Negative Breast Cancer: Biomarker Evaluation of the IMpassion130 Study
Leisha A. Emens, Luciana Molinero, Sherene Loi, Hope S. Rugo, Andreas Schneeweiss
Journal of the National Cancer Institute. 2021-08-02
14 citations
Independent radiologic review of AURELIA, a phase 3 trial of bevacizumab plus chemotherapy for platinum-resistant recurrent ovarian cancer.
Amreen Husain, Yan Wang, Lars Hanker, B. Ojeda, Maarit Anttila
Gynecologic Oncology. 2016-09-01
214 citations
Final overall survival and safety analysis of OCEANS, a phase 3 trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent ovarian...
Carol Aghajanian, Barbara A. Goff, Lawrence R. Nycum, Yan V. Wang, Amreen Husain
Gynecologic Oncology. 2015-10-01

Journal Articles

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
Amreen Husain, Sylvia Adams, Hope S Rugo, Carlos H Barrios, Eric P Winer, The New England Journal of Medicine